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Abstract
Leucine-responsive regulatory protein (Lrp) is known to be an indirect activator of type 1 fimbriae synthesis in Salmonella
enterica serovar Typhimurium via direct regulation of FimZ, a direct positive regulator for type 1 fimbriae production. Using RT-
PCR, we have shown previously that fimA transcription is dramatically impaired in both lrp-deletion (Dlrp) and constitutive-lrp
expression (lrpC) mutant strains. In this work, we used chromosomal PfimA-lacZ fusions and yeast agglutination assays to confirm
and extend our previous results. Direct binding of Lrp to PfimA was shown by an electrophoretic mobility shift assay (EMSA) and
DNA footprinting assay. Site-directed mutagenesis revealed that the Lrp-binding motifs in PfimA play a role in both activation
and repression of type 1 fimbriae production. Overproduction of Lrp also abrogates fimZ expression. EMSA data showed that
Lrp and FimZ proteins independently bind to PfimA without competitive exclusion. In addition, both Lrp and FimZ binding to
PfimA caused a hyper retardation (supershift) of the DNA-protein complex compared to the shift when each protein was present
alone. Nutrition-dependent cellular Lrp levels closely correlated with the amount of type 1 fimbriae production. These
observations suggest that Lrp plays important roles in type 1 fimbriation by acting as both a positive and negative regulator and
its effect depends, at least in part, on the cellular concentration of Lrp in response to the nutritional environment.
Citation: Baek C-H, Kang H-Y, Roland KL, Curtiss R III (2011) Lrp Acts as Both a Positive and Negative Regulator for Type 1 Fimbriae Production in Salmonella
enterica Serovar Typhimurium. PLoS ONE 6(10): e26896. doi:10.1371/journal.pone.0026896
Editor: Dipshikha Chakravortty, Indian Institute of Science, India
Received August 23, 2011; Accepted October 5, 2011; Published October 28, 2011
Copyright:  2011 Baek et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant (R01AI060557, Salmonella Vaccines Against Bacterial Enteropathogens) from National Institutes of Health. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rcurtiss@asu.edu
Introduction
Type 1 fimbriae are mannose-sensitive agglutination factors that
mediate bacterial adhesion to a broad range of eukaryotic cells by
interactions with mannosylated glycoproteins [1–3]. Most members
of the family Enterobacteriaceae, including Salmonella enterica serovar
Typhimurium, produce type 1 fimbriae that are believed to
contribute to pathogenesis by facilitating the initial interaction with
host cells [3–5]. The fim gene cluster, responsible for type 1 fimbriae
production, is composed of six structural genes, fimAICDHF
transcribed as an operon from the fimA promoter, three regulatory
genes, fimZ, fimY, and fimW, and an arginine tRNA gene, fimU [6].
The structural gene products are the major type 1 fimbrial subunit
FimA [7,8], fimblin-like protein FimI [9], periplasmic chaperone
FimC [10], outer membrane usher protein FimD [6], minor fimbrial
subunit FimH (adhesin) [11], and fimbrial-like protein FimF [6,11].
The regulatory fimZ, fimY, and fimW genes are expressed from
independent promoters [12–14]. The FimZ regulator activates
expression of the fimAICDHF operon by binding to the fimA
promoter [15]. In serovar Typhimurium, FimY and FimW act as a
transcriptional coactivator and repressor, respectively, through
protein-protein interactions with FimZ [12,14]. However, Saini et
al. reported that FimY independently activates the fimA promoter,
and FimW acts as a negative regulator by repressing FimY
transcription [16]. The fimU gene product arginine tRNA acts as a
posttranscriptional regulator by affecting FimY translation [17,18].
Bacteria are efficient at switching between type 1 fimbriate and
non-fimbriate status in response to environmental conditions
[3,19]. The mechanism of phase-variable type 1 fimbriae synthesis
has been well characterized in Escherichia coli [20]. FimB and FimE
recombinases mediate site-specific recombination of the fimA
promoter region, resulting in alteration of orientations allowing or
blocking transcription [20,21]. Nucleoid-binding global regulators
that modulate DNA topology, such as Lrp, integration host factor
(IHF), and H-NS affect phase variation and synthesis of type 1
fimbriae in E. coli [22–27]. In addition, McClain et al. suggested
that there is an inversion-independent phase variation mechanism
[28]. Despite significant homology between the fim structural
genes, the mechanism by which type 1 fimbriae synthesis is
regulated in S. enterica serovar Typhimurium differs substantially
from that in E. coli. The serovar Typhimurium fimA promoter does
not possess a cis-acting regulatory DNA element for reversible
inversion-dependent regulation of type 1 fimbriae expression [29].
Moreover, homologs of the E. coli FimB and FimE recombinase
are not present in serovar Typhimurium [30,31]. Conversely, no
homologs for serovar Typhimurium FimZ, FimY and FimW
regulators have been found within the E. coli fim gene cluster [32].
In serovar Typhimurium, Lrp is required for type 1 fimbriae
production by activating FimZ synthesis [33], whereas in E. coli,
Lrp is involved in inversion-dependent phase variation [26]. Lrp
activates fimZ expression by binding directly to the PfimZ promoter
[33]. FimZ is an essential positive regulator for type 1 fimbriae
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production in serovar Typhimurium [13]. Thus an lrp-deletion
mutant cannot produce FimZ, and is blocked for type 1
fimbriation [33].
Although, the mechanism for type 1 fimbriae production in
bacteria has been extensively studied, no clear mechanism for on-
off switching in response to environmental cues has been
demonstrated. We have proposed that dynamic change in cellular
Lrp levels in response to nutritional state (feast or famine) is
important for coordinating virulence traits in Salmonella [34]. In
this study, we address the effect of Lrp on type 1 fimbriation in
Salmonella.
Results
Lrp acts as both positive and negative regulator for fimA
expression
In our previous study using RT-PCR, we observed that an lrpC
(constitutive Lrp expression) mutation abrogated fimA transcription
[34]. The lack of fimA expression in the lrpC strain was unexpected,
since Lrp is known to be an indirect positive regulator for type 1
fimbriae production by enhancing expression of the positive
regulator FimZ [33]. To further define the role of Lrp in fimA
expression, we determined the activity of PfimA using PfimA-lacZ
fusions in wild-type strain x3761, and isogenic Dlrp and lrpC
mutant strains (Table 1) by measuring the b-galactosidase activity
in each of these strains after static, 24 h growth in LB medium at
37uC (Fig. 1A). The lack of b-galactosidase synthesis in the Dlrp
and lrpC mutant backgrounds indicates that transcription from
PfimA is not active in the absence of Lrp or when Lrp is
overproduced.
Next, we measured fimbriae production by determining the
ability of static cultures of strains x3761, x9411 (Dlrp) and x9448
(lrpC) to agglutinate yeast cells. Wild-type cells displayed mannose-
sensitive agglutination, while both mutant strains were deficient in
this phenotype (Fig. 1B), consistent with our observations that no
fimA transcript was detected in the strains. We further confirmed
Table 1. Bacterial strains and plasmids used in this study.
Strains Descriptiona [parental strain] Source
S. Typhimurium
x3761 Wild-type strain UK-1, highly virulent for chicks and mice [52,53]
x9411 Dlrp-13 (lrp-deletion mutation) [x3761] [34]
x9448 lrp-1281 (DPlrp::Ptrc lrp, chromosomal deletion-insertion mutation to drive constitutive expression of Lrp (lrp
C)) [x3761] [34]
x9449 DrelA198::araC PBAD lacI TT DaraBAD23 lrp-1281 [x9509] [34]
x9455 PfimA::pYA4311 (PfimA-lacZ), Amp
r Gmr [x3761] This study
x9467 Dlrp-13 PfimA::pYA4311 (PfimA-lacZ), Amp
r Gmr [x9411] This study
x11107 PfimA413 (a mutation) [x3761] This study
x11111 PfimA529 (b mutation) [x3761] This study
x11115 PfimA1225 (c mutation) [x3761] This study
x11153 lrp-1281 PfimA529 [x9448] This study
x11263 lrp-1281 PfimA::pYA4311 (PfimA-lacZ), Amp
r Gmr [x9448] This study
x11264 PfimA413::pYA4311 (PfimA413-lacZ), Amp
r Gmr [x11107] This study
x11265 PfimA529::pYA4311 (PfimA529-lacZ), Amp
r Gmr [x11111] This study
x11266 PfimA1225::pYA4311 (PfimA1225-lacZ), Amp
r Gmr [x11115] This study
x11267 lrp-1281 PfimA529::pYA4311 (PfimA529-lacZ), Amp
r Gmr [x11153] This study
x11377 PfimA1325 (ac double mutation) [x11115] This study
x11378 PfimA1329 (ab double mutation) [x11107] This study
x11379 PfimA2925 (bc double mutation) [x11115] This study
x11380 PfimA395 (abc triple mutation) [x11379] This study
E. coli
MGN-617 (x7213) thr-1 leuB6 fhuA21 lacY1 glnV44 recA1 DasdA4 thi-1 RP4-2-Tc::Mu [l-pir], Kmr [54]
Plasmids
pRE112 Positive selection suicide vector (R6K ori) for gene replacement, Cmr [55]
pSG3 a suicide vector (R6K ori) for construction of promoter-lacZ fusion into chromosome [49]
pWSK29 a low-copy-number cloning vector (pSC101 ori), Ampr [47]
pYA4124 Derivative of pET SUMO containing His Tag from pET-14b, Kmr [34]
pYA4311 Derivative of pSG3 for insertion of the PfimA-lacZ fusion into the chromosome, Amp
r Gmr This study
pYA4758 Derivative of pRE112 for replacement of the PfimA with PfimA413, Cm
r This study
pYA4759 Derivative of pRE112 for replacement of the PfimA with PfimA529, Cm
r This study
pYA4801 Derivative of pRE112 for replacement of the PfimA with PfimA1225, Cm
r This study
pYA4865 Derivative of pWSK29 harboring a recombinant fimZ gene, Ampr This study
aAmpr, ampicillin resistance; Gmr, gentamicin resistance; Cmr, chloramphenicol resistance; Kmr, kanamycin resistance.
doi:10.1371/journal.pone.0026896.t001
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these results by transmission electron microscopy (TEM). Typical
type 1 fimbriae appendages were detected on the cell surface of
wild-type strain x3761, while no type 1 fimbriae were detected on
the cell surface of the Dlrp or the lrpC strains (data not shown).
These results demonstrate that deletion of lrp or overproduction of
Lrp has a strong negative effect on type 1 fimbriae synthesis by
directly influencing fimA transcription.
Lrp directly interacts with PfimA
Based on our previously described consensus sequences [34], we
detected four putative Lrp-binding motifs in the PfimA region. All
four motifs are located upstream of the fimA transcription start site
(+1) [15]. The DNA motifs 1 [2308 to 2301], 2 [2112 to 2105],
and 3 [235 to 228] belong to Lrp-binding consensus IV, 59-
GNN(N)TTTT -39 [34,35] and DNA motif 4 [231 to 220]
belongs to Lrp-binding consensus III, 59- HNDWTTATTHND -
39 [where H=not G; W=A or T; D=not C; N= all bases; and
(N) = all bases or none] [34]. DNA motif 2 lies just upstream and
motifs 3 and 4 lie just downstream of the FimZ binding site [298
to 247] [33]. These observations led us to postulate that Lrp acts
as both an activator and a repressor for type 1 fimbriae expression
mediated by differential interactions with Lrp-PfimA, depending on
cellular concentration of Lrp and on environmental conditions. To
address this hypothesis, we tested the direct interaction between
Lrp and PfimA using the electrophoretic mobility shift assay
(EMSA). Lrp directly interacted with PfimA in a concentration-
dependent manner (Fig. 2). These results are in contrast to the
study by McFarland et al who did not detect an Lrp-PfimA
interaction in gel shift assays [33]. We noted differences in the
binding buffer used in their study compared to ours. Of particular
interest was the fact that their binding buffer included MgCl2,
while ours did not include divalent cations and, instead included
EDTA to chelate any divalent cations present. We performed the
EMSA assay using McFarland’s binding buffer and, like McFar-
land et al, did not detect binding (data not shown), suggesting that
the magnesium concentration may play a role in regulating Lrp
binding to PfimA.
A DNase I footprinting analysis was performed to elucidate in
more detail the molecular nature of the Lrp-PfimA interaction with
both coding (Fig. 3A) and non-coding (Fig. 3B) strands. A 388-bp
DNA probe extending from -334 to +54 with respect to
transcriptional start site (+1) was used, which includes the entire
PfimA region. The footprint was estimated by densitometry
comparing two lanes for 150 nM and 0 nM Lrp. Sites protected
from or hypersensitive to DNase I are summarized in Fig. 3C. All
four putative Lrp-binding motifs were protected by Lrp (Fig. 3A
and B). We observed strong protection of the DNA region (2326
to 2257) containing the Lrp-binding motif 1, while protection of
the DNA regions (2123 to2102;259 to233; and226 to26) of
the Lrp-binding motifs 2, 3, and 4, respectively, was weaker. The
DNA region (25 to +4) in immediate downstream of the Lrp-
binding motif 4 also showed weak protection. The AT-rich
overlapping region (234 to228) within Lrp-binding motif 3 and 4
was highly resistant to DNase I digestion. The FimZ-binding
region partly overlapped with the Lrp-binding region (259 to
247) (Fig. 3C). This result suggests that both Lrp and FimZ
competitively interact with the overlapped motif in PfimA. Two
Figure 1. Expression of type 1 fimbrial operon and the associated phenotype in the wild-type (WT, x3761), Dlrp (x9411), and lrpC
(x9448) strains. (A) b-galactosidase assay for the PfimA-lacZ fusions in each strain is shown. *, P,0.05 (B) Mannose-sensitive yeast agglutination
assay to assess type 1 fimbriae synthesis. Representative images from several experiments are shown. Bacterial cells were statically grown in LB broth
for 24 h at 37uC.
doi:10.1371/journal.pone.0026896.g001
Figure 2. Binding of the purified Lrp to the wild-type PfimA.
Binding reactions were carried out in various Lrp concentrations: 0, 50,
100, 150, and 200 nM. The 178-bp DNA fragment from pBluescript
multi-cloning sites was used as the negative control.
doi:10.1371/journal.pone.0026896.g002
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super-hypersensitive positions (red arrowheads in Fig. 3A and B),
2193 T on coding strand and 2130 G on non-coding strand,
were detected. None of tested DNA fragments showed non-specific
degradation in the absence of DNase I (data not shown).
Each of the Lrp-binding motifs in PfimA plays a distinct
role in regulating type 1 fimbriae production
To dissect the role of Lrp interactions with the promoter region
of fimA, we constructed PfimA mutations, PfimA413, PfimA529, and
PfimA1225, designated a, b, and c, respectively, in the Lrp-binding
motifs by site-directed mutagenesis (Table 1 and Fig. 3C). Our
strategy for these mutations was to change multiple bases in each
of the Lrp-binding motifs to increase the likelihood of disrupting
the Lrp-DNA interaction and to reduce the likelihood of reversion.
In addition, the GC content (25% or less) of the Lrp-binding
motifs was increased by the changes to achieve a GC content
closer to the average for Salmonella, approximately 52% [6]. The
GC content was raised to 50% by the a and b mutations and to
44% by the c mutation. None of the changes affected bases known
to be part of the RNA polymerase binding site for PfimA.
To determine the influence of the PfimA mutations on
expression, we estimated the levels of mannose-sensitive fimbriae
by a yeast agglutination assay, the synthesis of FimA by western
blot, and fimA expression using chromosomal fimA-lacZ fusions in
strains carrying the promoter mutations (Fig. 4). The PfimA413 (a)
mutation had no significant effect on yeast agglutination, FimA
synthesis or fimA transcription when compared to wild-type PfimA
[PfimA(WT)] (Fig. 4A and B). In contrast, the PfimA529 (b) mutation
resulted in a substantial increase in FimA synthesis (Fig. 4A) and a
simultaneous increase in agglutination even at the lowest cell
density used. In contrast, the PfimA1225 (c) mutation resulted in loss
of the agglutination phenotype and no detectable FimA synthesis
on day 1 of growth (Fig. 4A). These results suggest that Lrp-
binding motifs 1 and 2 in the PfimA region are involved in Lrp-
mediated activation and repression, respectively, of type 1 fimbrial
gene expression. Overall, the results from the lacZ fusion studies
mirrored the yeast agglutination and western blot results (Fig. 4A,
4B). The double and triple mutants, PfimA1325 (ac), PfimA1329 (ab),
PfimA2925 (bc), and PfimA395 (abc) displayed wild-type levels of yeast
agglutination on both day 1 and day 3 (data not shown).
Interestingly, we observed wide experiment-to-experiment
variations in fimA expression on day 1, as measured by b-
galactosidase synthesis from the PfimA1225 (c)-lacZ fusion (Fig. 4B).
Yeast agglutination results from the c mutant (culture at day 1)
were also variable among independent experiments (data not
shown). Upon plating the c mutant cultures after three days of
growth, we observed heterogeneous colony morphologies, includ-
ing large and small colonies. Some of the large colonies were
purified and retested. They appeared to be highly fimbriated, as
they agglutinated yeast strongly after 24 hours of static growth and
synthesized FimA (data not shown), suggesting that they had
acquired a suppressor mutation. This observation could explain
the variable data from the original c-lacZ-fusion mutant culture at
day 1 (Fig. 4B). By day 3, we observed strong yeast agglutination
(Fig. 4A) and higher levels of b-galactosidase synthesis than wild
type (Fig. 4B), consistent with the accumulation of these highly
fimbriated, faster-growing spontaneous mutants in the culture
(data not shown). To determine whether or not the suppressor
mutation was in the fim regulatory region, we picked four of these
mutants and determined the DNA sequence of the entire
promoter region. However, we could not find any additional
mutations in the PfimA1225 (c) DNA sequence from the suppressor
mutants, indicating that the suppressor mutation is located
elsewhere in the chromosome (data not shown).
Each of the Lrp-binding motifs in PfimA contributes to
Lrp-PfimA interaction
To address the mechanism behind the Lrp-mediated dual
(activation/repression) regulation, interactions between Lrp and
each of the mutant fimA promoters were evaluated using EMSA.
Lrp binding to the the a, b, c, ac, ab, and bc (single and double)
mutant promoters was indistinguishable from binding to Pfi-
mA(WT) regardless of Lrp concentrations. In contrast, Lrp binding
to the abc triple mutant promoter was impaired when the Lrp
concentration was reduced to 100 nM or 50 nM (Fig. 5). This
indicates that each of the Lrp-binding motifs in PfimA contributes
to Lrp-PfimA interactions. Leucine had a minor effect on the band
pattern, but we observed no significant effect on the binding
affinity of Lrp to PfimA(WT) (data not shown). In addition, there
was no significant effect of leucine on the Lrp-PfimA footprint (data
not shown).
Lrp acts as both positive and negative regulator of fimZ
expression
The increase in fimA expression observed in the b mutant
(Fig. 4B) raised the possibility that the binding of Lrp to motif 2,
adjacent to the FimZ binding site (Fig. 3C), may affect FimZ
binding. If the b mutation precluded Lrp binding, this could allow
for greater accessibility of FimZ to its binding site in PfimA, thereby
accounting for the observed hyper-fimbriation phenotype of the b
mutant. To address this possibility, we investigated whether the b
mutation could relieve the observed repression of fimA in the lrpC
mutant. Therefore, we introduced the b mutation into the lrpC
mutant and evaluated the resulting strain. We found that
introduction of the b mutation did not alleviate the Fim-
phenotype in lrpC mutant (Fig. 4). The new strain was essentially
identical to the lrpC mutant carrying the PfimA (WT). It did not
produce any detectable FimA (Fig. 4A), did not agglutinate yeast
cells, and no fimA transcription was detected from the b mutant
promoter (Fig. 4B). Because FimZ is a positive activator of fimA
expression, we assessed fimZ expression in the lrpC mutant by RT-
PCR analysis. We found that fimZ expression was undetectable in
both the Dlrp and lrpC mutants (Fig. 6A). The results within the
Dlrp mutant are consistent with previous observations that Lrp is a
positive activator of fimZ [33]. The lack of fimZ expression in the
lrpC mutant indicates that Lrp can also act as a negative regulator
of fimZ. In addition, complementation with plasmid-borne (Lrp-
Figure 3. DNase I footprinting of Lrp binding to the PfimA region. Both coding (A) and noncoding (B) strands were subjected to the DNase I
protection assay. These strands were 32P-labeled at 59 ends as described in Materials and Methods. Lrp was added at 150, 100, 50, and 0 nM. The
DNase I protection products were separated in a sequencing gel next to the corresponding DNA sequencing products (lanes G, A, T, and C). The
results from panels A and B are summarized in panel C. The coordinates in the panels A, B, and C are numbered with respect to the fimA transcription
start site (+1) [15]. The black open boxes indicate DNA bases that were protected from DNase I digestion by Lrp. Hypersensitive bases are indicated
with red arrowheads. The putative Lrp-binding motifs are shown as purple bars on the left side of the gels, and are underlined (purple) in panel C.
Base changes in the site-directed mutations of the Lrp-binding motifs are shown over the wild-type bases. The FimZ-binding region [15] is also
underlined (black). The putative 235 and 210 consensus sequences for RNA polymerase are shown in blue letters. The translation start codon (ATG)
for the fimA gene is shown in bold letters. Arrows indicate orientation of transcription or translation.
doi:10.1371/journal.pone.0026896.g003
Regulation of Type 1 Fimbriae Production by Lrp
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26896
independent) fimZ can overcome the loss of type 1 fimbriae
production in the lrpC mutant in both wild-type PfimA and PfimA529
(b) backgrounds (Fig. 6B). Therefore, it appears that even if Lrp
binding is reduced at the Lrp-binding motif 2 when the bmutation
is present, no fimA is expressed due to repression of fimZ. In
addition, positive regulation of fimA expression by FimZ is
dominant over the negative regulation by Lrp when fimZ is
overexpressed.
Both Lrp and FimZ independently bind to PfimA
To gain greater insight into the regulation of fimA expression by
Lrp and FimZ, we evaluated the binding of Lrp and FimZ to PfimA
at several different molar ratios. First, we confirmed that purified
FimZ directly interacted with PfimA (Fig. 7A). When the
concentration of FimZ was held constant at 50 nM, the intensity
of shifted DNA-protein complex was increased by adding Lrp in a
concentration dependent manner (Fig. 7B). Similarly, when the
Lrp concentration was held constant at 50 nM, the intensity of
shifted DNA-protein complex was increased by adding FimZ in a
concentration dependent manner (Fig. 7B). In contrast to these
conditions, in presence of Lrp (50 nM) or FimZ (12.5 nM) alone,
the PfimA-Lrp or PfimA-FimZ complexes ran as a smear in the gel
(Fig. 7A and B). These results indicate that both Lrp and FimZ
independently bind to PfimA. Although, DNase I footprinting
analysis showed that the FimZ-binding motif partly overlapped
with the Lrp-binding region (Fig. 3B and C), we could not obtain
any evidence for competitive binding of Lrp and FimZ to PfimA
using EMSA. In addition, in the presence of both Lrp and FimZ,
Figure 4. Effect of Lrp-binding motif mutations in PfimA on type 1 fimbriae production and b-galactosidase synthesis directed by
PfimA promoter fusions in the indicated Salmonella strains. Salmonella strains each harboring one of the PfimA mutations were statically grown
in LB broth at 37uC for one day (24 h) or 3 days. Mannose-sensitive yeast agglutination assay and western blot analysis were performed to monitor
fim expression in the single mutants (A). Agglutination was scored as follows: -, none; ++, good; +++, strong; and ++++, very strong. Immunoblots
using anti-FimA serum in each panel determine the level of FimA synthesized in each mutant. (B) b-galactosidase assay for a each lacZ fusion strain is
shown. *, P,0.05; N.S., not significant.
doi:10.1371/journal.pone.0026896.g004
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we observed an increase in the apparent size of the PfimA(WT)
complex (supershift) compared to the shift when each protein was
present alone (Fig. 7C). To identify the Lrp-binding motif(s)
responsible for the supershift, we estimated the binding of Lrp and
FimZ to each of the mutant promoters, PfimA413 (a), PfimA529 (b),
and PfimA1225 (c). The c mutation in motif 1 abrogated the
supershift of the DNA-protein complex, while the a and b
mutations maintained the supershift (Fig. 7C). Remarkably, the a
mutation led to a very strong supershift (Fig. 7C). These results
indicate that the Lrp-binding motif 1 and the FimZ-binding motif
in PfimA allow the supershifting of the PfimA complex by binding of
both Lrp and FimZ to PfimA.
The cellular level of Lrp is a key factor for on/off
switching of type 1 fimbriae production in serovar
Typhimurium
To examine Lrp-dependent on/off switching of type 1 fimbriae
production, we employed S. Typhimurium strain x9449 harboring
an arabinose-dependent Lrp expression system (araC PBAD lacI and
Ptrc lrp) [34]. In the presence of arabinose, lacI expression is
induced and lrp expression, transcribed from the lacI-regulated Ptrc
promoter, is repressed. Conversely, in the absence of arabinose, no
LacI is produced and Lrp is synthesized (Fig. 8A). In strain x9449,
Lrp synthesis and the ability to agglutinate yeast cells were
dependent on the arabinose concentration in LB medium (Fig. 8A).
To evaluate whether the nutrition-dependent cellular Lrp levels
are related to on-off switching of type 1 fimbriation, wild-type
strain x3761 was statically grown in MOPS minimal broth, LB
broth, and MOPS plus LB (MOPS-LB) broth mixed in several
different ratios. Cells from these cultures were harvested and tested
for mannose-sensitive yeast agglutination. Cell lysates were
analyzed by western blot using anti-Lrp mouse serum. As shown
in Fig. 8B, Lrp synthesis was proportional to the nutritional
content of the growth medium: with more Lrp produced under
poor nutritional conditions and less Lrp produced under rich
nutritional conditions. Mannose-sensitive yeast agglutination was
dramatically reduced in the Salmonella cells grown in MOPS
minimal medium, which is the condition generating the highest
cellular Lrp level (Fig. 8B). Mannose-sensitive agglutination was
partially recovered in the bacterial cells grown in MOPS minimal
broth supplemented with 1% (v/v) LB broth (Fig. 8B). The wild-
type Salmonella completely recovered mannose-sensitive type 1
fimbriation in the MOPS-LB media containing 10% (v/v) LB
broth or more (Fig. 8B). These results imply that the nutrition-
Figure 5. Effects of Lrp-binding motif mutations in PfimA by EMSA. Lrp was added at 150, 100, 50, and 0 nM. Reaction products were
separated in a 5% polyacrylamide gel. Data presented are representative of two independent observations.
doi:10.1371/journal.pone.0026896.g005
Figure 6. Effect of cellular Lrp levels on FimZ synthesis and
PfimA-FimZ interaction in Salmonella. (A) RT-PCR analysis of fimZ
transcript in the wild-type (WT, x3761), Dlrp (x9411), and lrpC (x9448)
strains. RT-PCR analysis of murA transcript in the strains was used as the
control. (B) Mannose-sensitive yeast agglutination assay to assess type 1
fimbriae production and western bolt analysis for the FimZ synthesis in
the lrpC mutants harboring pWSK29 (a low-copy number vector control)
or pYA4865 (Lrp-independent fimZ expression vector).
doi:10.1371/journal.pone.0026896.g006
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dependent intracellular Lrp concentration is important for
regulating type 1 fimbriation.
To get a better sense of how much Lrp is present in cells, we
estimated the number of Lrp molecules per cell when cells were
grown in MOPS minimal broth, LB broth, and MOPS plus LB
(MOPS-LB) broth mixed in several different ratios by comparing
the western blot shown in Fig. 8B with a western blot loaded with
known amounts of purified Lrp (Fig. 8C). Based on our
densitometry calculations using the standard curve in Fig. 8C,
the wild-type Salmonella strain x3761 produced about 6,000 Lrp
molecules (3,000 dimers) per cell when grown in MOPS minimal
medium. This is the same number of Lrp molecules calculated for
E. coli cells grown in a glucose-based minimal medium [36]. The
wild-type Salmonella strain x3761 produced about 2,000 Lrp
molecules (1,000 dimers) per cell in LB medium, whereas the lrpC
mutant produced about 12,000 Lrp molecules (6,000 dimers) per
cell grown in LB medium (data not shown). In MOPS minimal
medium supplemented with 10% (v/v) LB, x3761 produced
approximately 4,700 Lrp molecules (2,350 dimers) per cell. In
addition, the regulated lrp-expression mutant x9449 produced
about 900 Lrp dimers per cell when grown in LB medium
supplemented with 0.04% or 0.2% arabinose, and did not produce
type 1 fimbriae. These results indicate that S. Typhimurium is able
to produce type 1 fimbriae at a range of cellular Lrp
concentrations (from 1,000 to 2,400 Lrp dimers per cell). In
MOPS minimal medium supplemented with 1% (v/v) LB, x3761
produced some type 1 fimbriae, as judged by the mannose-
sensitive yeast agglutination assay, even though this strain
produced 3,000 Lrp dimers per cell, more than the 2,400 dimers
per cell predicted to be the maximum number that would permit
fimA transcription, based on growth in MOPS. This result suggests
that nutritional signals in LB broth may partially relieve the Lrp-
mediated repression of type 1 fimbriation at high cellular Lrp
concentration. Identification of the nutritional signals in LB
medium remains to be addressed.
Discussion
Lrp is required for synthesis of type 1 fimbriae [33]. Previous
studies have shown that FimZ is required for fimA expression and Lrp
is required for fimZ expression [33]. Lrp binds to the fimZ promoter
region and can thereby enhance fimZ expression [33]. FimZ binds to
PfimA and activates fimA expression. Our previous report showed that
while Dlrp mutants did not express fimA as expected, neither did lrpC
mutants [34]. To address the basis for these apparently contradictory
phenomena, we investigated the role of Lrp in regulating type 1
fimbriae synthesis in more detail. Using both genetic and molecular
approaches, we found that high cellular levels of Lrp repressed fimA
expression, with a concomitant loss of the type 1 fimbriae-associated
mannose-sensitive agglutination phenotype (Fig. 4). Under these
conditions, production of FimZ is also abrogated (Fig. 6). Site directed
mutagenesis of putative Lrp-binding sites in the fimA promoter
indicated that binding of Lrp to the fimA promoter is necessary for
both activation and repression of type 1 fimbriae expression (Fig. 4).
Figure 7. Binding of the purified Lrp and FimZ proteins to PfimA. (A) Binding of FimZ to PfimA(WT). (B) Binding of Lrp and FimZ to PfimA(WT). (C)
Binding of Lrp and FimZ to PfimA(WT), PfimA413 (a), PfimA529 (b), or PfimA1225 (c). The white arrowheads indicate super-shifted Lrp-PfimA-FimZ complexes.
To enhance resolution of the super-shifted DNA-protein complexes, the running time of the polyacrylamide gel in panel C was extended from 1 h
(used in panels A and B) to 2 h. Schematic diagrams of the wild-type and mutant fimA promoters are shown under the gel.
doi:10.1371/journal.pone.0026896.g007
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The cmutation in the Lrp-binding motif 1 (Fig. 3B) abolished type 1
fimbriae synthesis, as judged by fimA expression and the yeast
agglutination phenotype (Fig. 4). These results suggest that Lrp-
binding motif 1 in PfimA may play a crucial role in Lrp-mediated
activation of type 1 production. This notion is supported by the
observation that the c mutation eliminates the formation of a
supershifted band in the EMSA assay (Fig. 7C), indicating that Lrp
binds to motif 1. In addition, the supershifting of this DNA-protein
complex suggests that both Lrp and FimZ binding to PfimA lead to a
change inDNA topology, since Lrp changes DNA topology by DNA-
protein and protein-protein interactions [37]. This DNA topology
change may contribute to activation of type 1 fimbriae production
under normal growth conditions in cells (neither the absence nor
overproduction of the regulators Lrp or FimZ). The precise
mechanism driving the activation of fimA transcription remains to
be elucidated.
The b mutation in Lrp-binding motif 2 (Fig. 3B) enhanced fimA
transcription and FimA synthesis (Fig. 4), indicating that the Lrp-
binding motif 2 in PfimA is important for repression of type 1
fimbriae production. Based on our results showing that Lrp binds
to motif 2 (Fig. 3B), we infer that repression via motif 2 is Lrp-
mediated. Introduction of the lrpC mutation into the b mutant
(PfimA529) repressed fimA expression and eliminated any detectable
yeast agglutination (Fig. 6B). This result is most easily explained by
the lack of fimZ expression in these cells (Fig. 6A), as the synthesis
of type 1 fimbriae is restored by overexpression of fimZ (Fig. 6B).
FimZ-dependent PfimA activation dominates the Lrp effect on
PfimA when fimZ is overexpressed (Fig. 6) and in fact, does not
require Lrp when expressed from a multicopy plasmid [33]. In
contrast to the effects observed in the b and c mutants, the a
mutation in Lrp-binding motif 3 and 4 had no effect on
agglutination or on transcription of the PfimA::lacZ fusion (Fig. 4).
The DNase I footprinting analysis showed that the protection
region at Lrp-binding motif 3 and 4 partly overlapped with the
FimZ-binding motif (Fig. 3). This result suggests that Lrp and
FimZ compete for binding to PfimA at the overlapping sites.
However, the EMSA results indicated that Lrp and FimZ
independently bind to PfimA without competitive exclusion.
Many Lrp-regulated genes include multiple Lrp-binding motifs
in their promoter region. Cooperative binding of Lrp to these
motifs is an important factor for Lrp-mediated gene regulation
[38]. Cooperative interactions between Lrp and other nucleoid-
binding proteins such as H-NS are thought to repress transcription
of some genes [39]. While Lrp has been shown to act as a positive
or negative regulator for each of the genes in the Lrp regulon, no
systematic study of the mechanism has been undertaken. Although
it is unusual for Lrp to be both a positive and a negative regulator
in the same operon, this type of dual regulation has been reported
for the papBA operon [40]. In that case, Lrp interacts with H-NS
for repression and PapI for activation.
The PfimA region of S. Typhimurium includes four Lrp-binding
motifs, 1, 2, 3, and 4 (Fig. 3C). Interestingly, three motifs are
located immediately upstream (motif 2) and downstream (3 and 4)
of the FimZ-binding cis element in PfimA [33]. Motif 1 is located far
upstream (2308 to 2301) from the fimA transcription start site
[15]. Moreover, two potential high-affinity H-NS binding sites
[41], 59- AAAATAAGA -39 (2100 to 292) and 59- AT-
TAAAAGA -39 (251 to 243), are located immediate downstream
of Lrp-binding motif 2 and upstream of Lrp-binding motif 3,
respectively, and overlap with the FimZ-binding site. This
observation suggests that Lrp binding to Lrp-binding motifs 2
and 3 may facilitate binding of the silencing protein H-NS. Site-
directed mutagenesis revealed that motifs 1 (distal locus for c
mutation) and 2 (proximal locus for b mutation) are important
determinants for activation and repression, respectively, of type 1
fimbriae production (Fig. 4). This result is consistent with previous
reports that Lrp acts as a repressor when bound to motifs closer to
or within the promoter and as an activator when bound to motifs
further upstream [35,42]. Similarly, we also found seven Lrp-
binding motifs in the PfimZ region (603-bp, between fimY stop
codon and fimZ start codon) (data not shown). Two motifs belong
to Lrp-binding consensus III (59- HNDWTTATTHND -39) and
five motifs belong to Lrp-binding consensus IV (59-
Figure 8. Effect of cellular Lrp levels on type 1 fimbriae
production in S. Typhimurium. (A) Western blot analysis for Lrp
synthesis and mannose-sensitive yeast agglutination assay for the type
1 fimbriation in strain x9449 grown statically at 37uC for 24 h in LB
medium supplemented with various arabinose concentrations. (B)
Western blot analysis for Lrp synthesis and mannose-sensitive yeast
agglutination assay in the wild-type strain x3761 grown statically in
various combination of MOPS and LB media at 37uC for 24 h.
Agglutination was scored as follows: -, no; +/-, very weak; +, weak;
and ++, good. (C) Preparation of standard curve for quantification of
cellular Lrp levels by western blot analysis of purified Lrp (100, 50, and
25 ng) using anti-Lrp antiserum and densitometry.
doi:10.1371/journal.pone.0026896.g008
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GNN(N)TTTT -39) [34,35]. Furthermore, three of the seven
motifs in PfimZ are strong Lrp-binding DNA sequences as
identified by DNA footprint analysis in a previous study [33].
One Lrp-binding motif in PfimZ is also located far upstream (2353
to 2346) from the fimZ transcription start site [33] similar to motif
1 in PfimA (Fig. 3C). A specific feature of the PfimZ region is that
two Lrp-binding motifs are located between the transcription start
site and the start codon of fimZ gene. Although the double and
triple mutations, PfimA1325 (ac), PfimA1329 (ab), PfimA2925 (bc), and
PfimA395 (abc) still can interact with Lrp, all of the multiple
mutants produced wild-type levels of yeast agglutination on both
day 1 and day 3 (data not shown). These results suggest that for
Lrp to exert its regulatory effect, it must bind to at least two Lrp-
binding motifs in PfimA. In the absence of cooperative binding, as is
the case in the double or triple mutants, PfimA expression would
not be under direct Lrp control. However, transcription from these
mutant promoters is still sensitive to regulation by FimZ. Thus
these promoters can be activated by FimZ and produce wild-type
levels of type 1 fimbriae when grown in LB broth. In addition, we
believe that the DNA motif 3 and 4 (a mutation position) can
facilitate cooperative binding of Lrp to the DNA motif 1 and motif
2, even if a mutation itself does not have any effect on type 1
fimbriae production. Therefore, the effects of b and c mutations
can be suppressed by adding a mutation. These observations
indicate that the cooperative binding of Lrp to multiple Lrp-
binding motifs in PfimA is important for Lrp-mediated regulation of
type 1 fimbriae production. Based on results from site-directed
mutagenesis of the multiple Lrp-binding motifs in PfimA, we
assume that the organization (proximity, number, and orientation)
of Lrp-binding motifs and their cooperative interaction with Lrp
play a crucial role for on/off switching of the fimZ gene expression.
Saini et al. suggested that inhibition of fim gene expression occurs
through the direct repression of PfimY by FimW, resulting in
prevention of FimY-mediated fimZ activation [16]. FimY is also a
transcriptional activator for fimA, fimW, and itself [14,16].
However, the positive and negative feedback loops are not
sufficient to explain the regulation of type 1 fimbriae synthesis,
since type 1 fimbriae synthesis under inducing conditions is
continuous or rheostat-like rather than an autocatalytic or switch-
like response [16]. These observations suggest that expression of
type 1 fimbriae in Salmonella cells is a collective and continuous
event in response to environmental milieu. These phenomena
could be well explained if we assume that Lrp can act as both
positive and negative regulators for type 1 fimbriae production
depending on intracellular levels of Lrp, which are closely related
with the nutritional environment [34,43]. In addition, mannose-
sensitive yeast agglutination correlated with nutrition-dependent
cellular Lrp levels (Figs. 8A and B). Based on the Lrp titration
results from the western blot analyses in Fig. 7B, we conclude that
mannose-sensitive type 1 fimbriation in Salmonella is inhibited by
Lrp at a concentration of 3,000 or more Lrp dimers per cell
(Fig. 8B) under nutrient-poor conditions. However, mannose-
sensitive yeast agglutination was observed in Salmonella producing
about 2,400 or fewer Lrp dimers per cell in nutrient-rich
environments (Fig. 8B). We estimated that the lrpC mutant
x9448 produces at least 6,000 Lrp dimers per cell grown in LB
medium. This cellular Lrp concentration is enough to inhibit type
1 fimbriae production, even when the Salmonella cells are grown in
LB broth, a rich medium. Therefore, our results indicate that a
narrow range of Lrp concentrations governs activation of fimA
transcription and production of type 1 fimbriae. Too much or too
little Lrp results in no type 1 fimbriae production, allowing the cell
to tightly regulate production of these complex extracellular
structures in response to the nutritional environment.
Based on these data, we propose here a revised model for the fim
gene regulatory circuit in S. Typhimurium (Fig. 9A). In our model,
Lrp modulates expression of fimA and fimZ, either positively or
negatively, depending on growth conditions and the amount of Lrp
present. When Lrp is present in excess (more than 3,000 dimers per
cell), as is the case in the lrpC mutant or during growth in nutrition-
poor media, no fimZ is expressed, and Lrp binds to all four motifs 1,
2, 3, and 4 in PfimA resulting in complete repression of fimA (Fig. 9B).
We assume that the binding of Lrp to motifs 2 and 3 may allow
binding of the silencing factor H-NS to the high affinity H-NS-
binding motifs in the FimZ-binding region, and competitively
exclude FimZ binding to the PfimA. This feature is similar to the
collaborative competition mechanism in eukaryotic gene regulatory
regions typically encompassing multiple DNA target sites for two or
more regulatory proteins within a space of a few hundred base pairs
or less [44]. At a lower range of Lrp concentrations (about
1,000,2400 dimers per cell), the levels of FimZ are high, such as
occurs when cells are grown in nutrient-rich conditions (e.g. LB
broth), FimZ is better able to occupy its activation site in PfimA,
presumably due to the fact the affinity of Lrp to motifs 2, 3, and 4 is
relatively weak (Fig. 3B) and there is an abundance of FimZ. Due to
the requirement of motif 1 for FimA and type 1 fimbriae synthesis
(Fig 4), we infer an interaction between Lrp and FimZ under these
conditions that enhance FimZ-mediated activation of fimA expres-
sion by changing the regional DNA secondary structure. Finally, in
the Dlrp strain, neither fimZ nor fimA are expressed. We conclude
that Lrp is a key regulator to direct on-off switching of type 1
fimbriae production by the concentration-dependent dual regula-
tion in S. Typhimurium in contrast to the recombination-mediated
phase-variable type 1 fimbriation in E. coli.
Materials and Methods
Bacterial strains, plasmids, culture conditions, and
reagents
Bacterial strains and plasmids used in this study are listed in
Table 1. S. Typhimurium and E. coli strains were routinely grown
in LB broth [45]. For analysis of type 1 fimbriae production, S.
Typhimurium strains were grown statically in MOPS minimal
broth [46] or LB broth at 37uC for 24 h or 3 days. Diaminopimelic
acid (DAP, 50 mg/ml) was added to LB medium for growing Dasd
mutant strains. Antibiotics were used as needed at the following
concentrations: ampicillin, 100 mg/ml; chloramphenicol, 20 mg/
ml; gentamicin, 20 mg/ml; kanamycin, 50 mg/ml; and tetracy-
cline, 10 mg/ml. All antibiotics and chemicals were purchased
from Sigma Chemical Company (St. Louis, MO) or Fisher
Scientific Inc (Pittsburgh, PA).
DNA manipulations
The primers used in this study are listed in Table 2. Plasmid DNA
was isolated by using QIAprep Spin Miniprep Kit (QIAGEN,
Valencia, CA). Restriction enzymes and DNA-modifying enzymes
were used as recommended by the manufacturers (Promega,
Madison, WI or New England Biolabs, Ipswich, MA).
To produce a His-tagged FimZ protein, a DNA fragment
containing the entire fimZ ORF was amplified from strain x3761
by PCR using primers, RCB-52 and RCB-53 (Table 2). This PCR
product was digested with NcoI/BamHI and ligated into
expression vector pYA4124 digested with the same enzymes
[34]. The recombinant fimZ gene was excised from the resulting
plasmid using XbaI/BamHI and cloned into a low-copy number
plasmid pWSK29 [47] using the same enzyme sites, to create
pYA4865.
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Purification of FimZ
x9448 (pYA4865) (Table 1) was used for synthesis of the His-
tagged FimZ fusion protein. Cells were grown to an early
stationary phase (optical density at 600 nm [OD600] of 1.2) in
LB medium at 37uC and harvested by centrifugation at 3,3006g
for 15 min at 4oC. The His-tagged FimZ fusion protein was
purified by using a nickel affinity gel system, Ni Sepharose 6 Fast
Flow (Amersham Bioscience).
Construction of the PfimA413, PfimA529, and PfimA1225
mutations
The fimA promoter (PfimA) region was amplified from x3761 by
PCR using primers RCB-56 and RCB-57 (Table 2). The resulting
PCR product was digested with ApaI/SacI and ligated with ApaI/
SacI-digested pBluescript SK-. The resulting plasmid was used as
a template DNA for site directed mutagenesis of the Lrp-binding
motifs in PfimA by inverse PCR using primers RCB-46 and RCB-
47 for PfimA413, RCB-48 and RCB-49 for PfimA529 and RCB-50
and RCB-51 for PfimA1225 (Table 2). The inverse PCR products
were digested with XhoI, BglII, or XbaI, and self-ligated, to create
plasmids carrying PfimA413, PfimA529, and PfimA1225 mutations,
respectively. The PfimA413, PfimA529, and PfimA1225 DNA fragments
were excised using KpnI/SacI restriction enzymes, and cloned
into the same restriction enzyme sites of suicide vector pRE112, to
create pYA4758, pYA4759, and pYA4801, respectively. These
suicide plasmids were introduced into serovar Typhimurium
strains by conjugation to construct the PfimA mutants, PfimA413,
PfimA529, and PfimA1225, by allelic exchange as previously described
[48]. Each of the PfimA413 and PfimA529 mutations were added to
the PfimA1225 mutant to generate double mutants PfimA1325 and
PfimA2925, respectively. The PfimA529 mutation was added to the
PfimA413 mutant to generate a double mutant PfimA1329. The
Figure 9. Model for Lrp and FimZ-mediated regulation of type 1 fimbriae production in Salmonella. (A) Summary of the regulatory circuit
for type 1 fimbriae production. Arrowed and blunted lines indicate activation and repression, respectively. (B) Molecular model for Lrp and FimZ-
mediated regulation of type 1 fimbriae production. Dotted arrows, access to binding sites;6, competitive exclusion of competitor binding; and
arrowed flag indicates the transcription start site [15]. [High], at high concentration of Lrp or FimZ; and [Low], at low concentration of Lrp or FimZ.
doi:10.1371/journal.pone.0026896.g009
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PfimA413 mutation was added to the PfimA2925 double mutant to
generate a triple mutant PfimA395.
Construction of lacZ fusions
A 357-bp DNA fragment containing the fimA promoter region
was amplified from x3761 by PCR using primers RCB-44 and
RCB-45 (Table 2). The PCR product was digested with ApaI and
BamHI, and was cloned into the unique ApaI/BamHI sites of
lacZ-fusion suicide vector pSG3 [49]. The resulting plasmid
pYA4311 was introduced by conjugation into various Salmonella
strains to obtain PfimA-lacZ fusions by a single crossover event as
previously described [49].
Yeast agglutination assay
Bacteria were grown statically in various media at 37uC for 24 h
and/or 3 days. Bacterial cells were harvested by centrifugation at
5,0006g for 5 min at room temperature. The cell pellet was gently
resuspended in phosphate-buffered saline (PBS) and serially diluted
in the same buffer to adjust the optical density at 600 nm [OD600] to
4.0, 0.8, or 0.16. Yeast cells were washed twice with PBS and diluted
to an OD600 of 7.0. Agglutination assays were carried out in 96 well
microtiter plates by incubating 25 ml of bacterial cell suspension
with the same volume of yeast cells in PBS at room temperature for
10 min with gentle orbital shaking. Mannose sensitivity was
demonstrated by the absence of agglutination when the assay was
performed in the presence of 2% (wt/vol) mannose.
b-Galactosidase assay
Bacterial cells were statically grown at 37uC for 24 h. b-
Galactosidase activity was measured as previously described [50].
Means 6 standard errors were calculated from four independent
assays.
Reverse transcription (RT)-PCR analysis
A 0.5 ml aliquot of bacterial culture was mixed with 1 ml of
RNAprotect Bacteria Reagent (QIAGEN, Valencia, CA) and
incubated for 5 min at room temperature. Cells were harvested by
centrifugation at 8,0006g for 5 min at room temperature. Total
RNA from the cell pellet was isolated using RNeasy Mini Kit
(QIAGEN). The RNA samples were treated with extra DNase I to
avoid any DNA contamination, and repurified using the column in
the kit. The DNA-free RNA samples were confirmed by PCR. A
200 ng sample of total RNA was used for semi-quantitative RT-
PCR with the OneStep RT-PCR kit (QIAGEN). RT was
performed for 30 min at 50uC, followed by heat inactivation of
the reverse transcriptase for 15 min at 95uC. PCR amplification
was performed in the same tube with the following cycling
conditions: 25 cycles with 30 s at 95uC for template denaturation,
30 s at 55uC for primer annealing, and 1 min at 72 uC for primer
extension. The primers for RT-PCR (expected sizes of PCR
products) were as follows: RCB-24 and RCB-25 for fimA (427 bp)
[34]; RCB-52 and RCB-53 for fimZ (757 bp); RCB-28 and RCB-
29 for murA (725 bp) [34] (Table 2). PCR products were separated
in a 1.0% agarose gel, stained with ethidium bromide, and
visualized on a UV transilluminator.
Electrophoretic Mobility Shift Assay (EMSA)
The wild-type PfimA, PfimA413, PfimA529, PfimA1225, PfimA1325,
PfimA1329, PfimA2925, and PfimA395 DNA fragments were amplified
from wild-type and mutant strains by PCR using primers RCB-54
and RCB-55 (Table 2). The multi-cloning site of pBluescript SK-
(MCS-pBS, 178 bp) was amplified by PCR using primers, RCB-
42 and RCB-43 (Table 2) and used as non-specific control DNA
[34]. These DNA fragments were tested for interaction with Lrp
protein by EMSA as previously described [34]. The reactions
Table 2. Primers were used in this study.
Name Sequence (59 to 39)
Related
product
RCB-24 GACCTCTACTATTGCGAG fimA
RCB-25 TCAACCAGCGACTGCTTC fimA
RCB-28 CCGCGCTAGCGCCGCGCGCGAGCCGGAAATTGTC murA
RCB-29 CGCAAGCTTTTCGCCTTTCACGCGTTCAATATTC murA
RCB-42 ACTAAAGGGAACAAAAGC MCS-pBS
RCB-43 GTAAAACGACGGCCAGTG MCS-pBS
RCB-44 CGTGGGCCCTCGTCGTTAATAG PfimA-lacZ
RCB-45 TTAGGATCCATGGATTTCCCTTGA PfimA-lacZ
RCB-46 CTATTCTCGAGTTAGCGAAATGTTTAATTTATTAC PfimA413
RCB-47 TAACTCGAGAATAGCCGCAAACTCTTTTAATG PfimA413
RCB-48 TGCAGATCTCCATACAAAATAAGATTAGACCCTTC PfimA529
RCB-49 TATGGAGATCTGCATTATGCCGCCCGATG PfimA529
RCB-50 GACTCTAGACCGTCAGAAGCGGGCCTCGCTGTC PfimA1225
RCB-51 GACGGTCTAGAGTCATCCCCT TTGACTTG PfimA1225
RCB-52 ATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCATGAAACCTGCATCTG fimZ (RT)
RCB-53 CGCGGATCCGACCTTCCTGATCAATTAC fimZ (RT)
RCB-54 TGTGGATCCAAGTCAAAGGGGATGAC PfimA (EMSA)
RCB-55 CCTGAGTATCAGACGCAG PfimA (EMSA)
RCB-56 ATCGGGCCCGATACGCTCCAGCAC PfimA
RCB-57 TTTGAGCTCGGCTTCAACGGTGAAGA PfimA
doi:10.1371/journal.pone.0026896.t002
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subjected to electrophoretic separation in a 5% polyacrylamide gel
in 16 Tris-borate-EDTA (TBE) (100 V for 1 h) or 1 6 Tris-
taurine-EDTA buffer (TTE) (75 V for 1 h). The gel was stained
with 1 6 SYBR Gold (Invitrogen), and DNA bands were
visualized on a UV transilluminator.
For the competitive binding assay, the PfimA DNA fragment was
mixed with different molar ratios of Lrp and FimZ in the DNA
binding buffer [15] with minor modification: 5 mM Tris-HCl
pH 7.5, 25 mM KCl, 0.5 mM EDTA, 0.5 mM dithiothreitol,
BSA (5 mg/ml), and 20% glycerol. The reaction mixture was
incubated at room temperature for 15 min, and was subjected to
electrophoresis in 16TTE buffer as described above.
DNase I footprinting
RCB-54 and RCB-55 primers were labeled with [c-32P]ATP
(PerkinElmer) using DNA 59 end-labeling system (Promega) for
non-coding and coding strands, respectively. The DNA probes
were amplified by PCR using primer sets, [c-32P]ATP-labeled
RCB-54 and unlabeled RCB-55 primers or vice versa. One pmol
of the labeled probe was used for DNase I foot printing analysis.
Lrp-DNA probe binding reactions were identical to the conditions
for EMSA excepting addition of poly(dI-dC) at 10 mg ml21
(Sigma) instead of MCS-pBS control DNA. One ml volume of
DNase I (0.1 unit, Ambion) in 16DNase I buffer was added to
the reaction and incubated at room temperature for 6 min. Five ml
volume of stop buffer (95% formamide, 20 mM EDTA, 0.05%
bromophenol blue, and 0.05% xylene cyanol) was added to the
reaction mixture and incubated at 75uC for 10 min. The [c-
32P]ATP-labeled RCB-54 and RCB-55 primers were also used for
DNA sequencing using Sequi_Therm EXCEL II DNA sequenc-
ing Kit (EPICENTRE Biotechnologies). The products of the
DNase I footprinting and the DNA sequencing reactions were
resolved by electrophoresis through a denaturing 7% polyacryl-
amide-7M urea gel in 16Tris-taurine-EDTA buffer. The gel was
subjected to autoradiography.
Western blot analysis
Protein bands from a 12% SDS polyacrylamide gel were
transferred to a nitrocellulose membrane. Western blot analysis
was performed as previously described [51]. Blots were probed
with rabbit anti-FimA, anti-Lrp, or anti-His6 monoclonal mouse
immunoglobulin G (IgG, Invitrogen). Alkaline phosphatase-
conjugated goat anti-rabbit IgG or goat anti-mouse IgG (Sigma)
was the secondary antibody, as appropriate.
Estimation of the number of Lrp molecules per cell
The number of Salmonella cells per ml was estimated by turbidity
and CFU. The Lrp concentration in the crude bacterial cell
extract was determined by western blotting next to dilutions of
purified Lrp using an anti-Lrp mouse antiserum [34]. We
calculated the number of Lrp molecules per ml based on the
western blots and then divided the estimated number of Lrp
molecules per ml by the number of cells per ml to obtain the
number of Lrp molecules per cell.
Densitometry
The relative band intensities were obtained by using a
computational densitometry program Quantity One (Bio-Rad).
Statistical Analysis
Statistical analysis was performed using t test (GraphPad).
Results are presented as the mean and SEM. A P value,0.05 was
considered statistically significant.
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